IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,383,027 | -15.5% | 303,962 | +31.0% | 0.00% | 0.0% |
| Q2 2023 | $1,636,439 | +143321.5% | 232,119 | +25.1% | 0.00% | 0.0% |
| Q1 2023 | $1,141 | +110.5% | 185,568 | +118.8% | 0.00% | 0.0% |
| Q4 2022 | $542 | -99.9% | 84,800 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $812,000 | -30.1% | 85,179 | -20.1% | 0.00% | -50.0% |
| Q2 2022 | $1,161,000 | -18.8% | 106,600 | +24.7% | 0.00% | +100.0% |
| Q1 2022 | $1,429,000 | -8.9% | 85,512 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $1,569,000 | -33.1% | 80,788 | -18.0% | 0.00% | -66.7% |
| Q3 2021 | $2,345,000 | -42.0% | 98,559 | -35.8% | 0.00% | -50.0% |
| Q2 2021 | $4,043,000 | – | 153,549 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |